Current Report Filing (8-k)
January 06 2017 - 8:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
January 6, 2017
Date of Report (Date of earliest event reported)
Chimerix,
Inc.
(Exact name of registrant as specified in its
charter)
Delaware
|
|
001-35867
|
|
33-0903395
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
of incorporation)
|
|
|
|
|
2505 Meridian Parkway, Suite 100
Durham, NC
|
|
27713
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code:
(919) 806-1074
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 7.01
|
Regulation FD Disclosure.
|
Attached hereto as Exhibit 99.1 and incorporated
herein by reference is a corporate update presentation to be utilized by Chimerix, Inc. at the 35th Annual J.P. Morgan Healthcare
Conference in San Francisco, California.
The information in this Item 7.01 and the attached
Exhibit 99.1 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities and
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 7.01 and
the attached Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to
the Securities Act of 1933, as amended.
Forward-Looking Statements
Statements contained in, or incorporated by
reference into, this Current Report on Form 8-K regarding matters that are not historical facts are “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties,
actual results may differ materially from those expressed or implied by such forward-looking statements. Risks are described more
fully in our filings with the Securities and Exchange Commission, including without limitation our most recent Quarterly Report
on Form 10-Q and other documents subsequently filed with or furnished to the Securities and Exchange Commission. All forward-looking
statements contained in this Current Report on Form 8-K speak only as of the date on which they were made. We undertake no obligation
to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.
|
Item 9.01
|
Financial Statements and Exhibits.
|
Exhibit No.
|
|
Description
|
99.1
|
|
Corporate update presentation of Chimerix, Inc.
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
Chimerix, Inc.
|
|
|
|
|
Dated: January 6, 2017
|
|
|
|
|
|
By:
|
/s/ Timothy W. Trost
|
|
|
|
Timothy W. Trost
|
|
|
|
Senior Vice President, Chief Financial Officer and Corporate Secretary
|
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024